If you did not have a chance to visit our booth or symposium or would like access to the scientific talks presented at the conference, here is an opportunity to download all the information you need.
Advances in our knowledge about fusion biomarker detection, resistance development mechanisms, and immuno-oncology are leading towards a change in the standard of care in many types of cancer. Continuous new biomarker implementation has recently become a norm for pathology laboratories and standardisation of the tests is a key requirement.
Learn more about thought leaders experiences.
For Research Use Only. Not for use in diagnostic procedures.